# Natalie Boytsov

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/natalie-boytsov/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,326 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 15 |
| i10-index | 22 |
| Last Known Institution | Providence College |
| OpenAlex ID | https://openalex.org/A5041685827 |
| Works | 84 |

## Researcher papers

- [Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004–2014](https://scholariq.org/papers/prevalence-of-rheumatoid-arthritis-in-the-united-states-adult-population-in/)
- [Osteoporosis Medication Use After Hip Fracture in U.S. Patients Between 2002 and 2011](https://scholariq.org/papers/osteoporosis-medication-use-after-hip-fracture-in-u-s-patients-between-2002-and/)
- [Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population](https://scholariq.org/papers/examining-the-effect-of-medication-adherence-on-risk-of-subsequent-fracture/)
- [Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study](https://scholariq.org/papers/treatment-patterns-and-overall-survival-of-patients-with-double-class-and-triple/)
- [Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population](https://scholariq.org/papers/examining-the-treatment-gap-and-risk-of-subsequent-fractures-among-females-with/)
- [Do Patients With Moderate or High Disease Activity Escalate Rheumatoid Arthritis Therapy According to Treat‐to‐Target Principles? Results From the Rheumatology Informatics System for Effectiveness Registry of the American College of Rheumatology](https://scholariq.org/papers/do-patients-with-moderate-or-high-disease-activity-escalate-rheumatoid-arthritis/)
- [Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population](https://scholariq.org/papers/treatment-patterns-of-newly-diagnosed-rheumatoid-arthritis-patients-from-a/)
- [Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis](https://scholariq.org/papers/impact-of-plan-level-access-restrictions-on-effectiveness-of-biologics-among/)
- [Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis](https://scholariq.org/papers/costs-associated-with-failure-to-respond-to-treatment-among-patients-with/)
- [The direct and indirect costs of adult atopic dermatitis](https://scholariq.org/papers/the-direct-and-indirect-costs-of-adult-atopic-dermatitis/)
- [US health care utilization and costs in adult patients with atopic dermatitis by disease severity](https://scholariq.org/papers/us-health-care-utilization-and-costs-in-adult-patients-with-atopic-dermatitis-by/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Medication Adherence and Compliance](https://scholariq.org/topics/medication-adherence-and-compliance/)
- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)

## Researcher university

- [Providence College](https://scholariq.org/institutions/providence-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.